South Africa Bronchodilators Market Size & Outlook
Related Markets
South Africa bronchodilators market highlights
- The South Africa bronchodilators market generated a revenue of USD 177.2 million in 2022 and is expected to reach USD 226.4 million by 2030.
- The South Africa market is expected to grow at a CAGR of 3.1% from 2023 to 2030.
- In terms of segment, beta-adrenergic bronchodilators was the largest revenue generating drug class in 2022.
- Beta-Adrenergic Bronchodilators is the most lucrative drug class segment registering the fastest growth during the forecast period.
Bronchodilators market data book summary
| Market revenue in 2022 | USD 177.2 million |
| Market revenue in 2030 | USD 226.4 million |
| Growth rate | 3.1% (CAGR from 2022 to 2030) |
| Largest segment | Beta-adrenergic bronchodilators |
| Fastest growing segment | Beta-Adrenergic Bronchodilators |
| Historical data | 2018 - 2021 |
| Base year | 2022 |
| Forecast period | 2023 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Beta-Adrenergic Bronchodilators, Anticholinergic Bronchodilators, Xanthine Derivatives |
| Key market players worldwide | GSK PLC, AstraZeneca PLC, Teva Pharmaceutical Industries Ltd, Cipla Ltd DR, Mylan, Merck KGaA, Merck & Co Inc, Novartis AG ADR, Boehringer Ingelheim, Sun Pharmaceutical Industries, Glenmark Pharmaceuticals |
Other key industry trends
- In terms of revenue, South Africa accounted for 0.8% of the global bronchodilators market in 2022.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Middle East & Africa, Saudi Arabia bronchodilators market is projected to lead the regional market in terms of revenue in 2030.
- UAE is the fastest growing regional market in Middle East & Africa and is projected to reach USD 128.2 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Bronchodilators Market Scope
Bronchodilators Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Glenmark Pharmaceuticals | View profile | 10001+ | Andheri, Maharashtra, India, Asia | http://www.glenmarkpharma.com |
| Mylan | View profile | 10001+ | https://www.mylan.in/ | |
| AstraZeneca PLC | View profile | 89900 | 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, United Kingdom, CB2 0AA | https://www.astrazeneca.com |
| Sun Pharmaceutical Industries | View profile | 10001+ | Mumbai, Maharashtra, India, Asia | http://www.sunpharma.com |
| Boehringer Ingelheim | View profile | 10001+ | Ingelheim Am Rhein, Rheinland-Pfalz, Germany, Europe | https://www.boehringer-ingelheim.com/ |
| GSK PLC | View profile | 70200 | 980 Great West Road, Brentford, Middlesex, United Kingdom, TW8 9GS | https://www.gsk.com |
| Cipla Ltd DR | View profile | 38955 | Ganpatrao Kadam Marg, Cipla House, Peninsula Business Park, Lower Parel, Mumbai, MH, India, 400 013 | https://www.cipla.com |
| Merck & Co Inc | View profile | 72000 | 126 East Lincoln Avenue, Rahway, NJ, United States, 07065 | https://www.merck.com |
| Merck KGaA | View profile | 62345 | Frankfurter Strasse 250, Darmstadt, HE, Germany, 64293 | https://www.emdgroup.com |
| Teva Pharmaceutical Industries Ltd | View profile | 37851 | 124 Dvora HaNevi’a Street, Tel Aviv, Israel, 6944020 | https://www.tevapharm.com |
| Novartis AG ADR | View profile | 76057 | Lichtstrasse 35, Basel, Switzerland, 4056 | https://www.novartis.com |
South Africa bronchodilators market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to bronchodilators market will help companies and investors design strategic landscapes.
Beta-adrenergic bronchodilators was the largest segment with a revenue share of 41.14% in 2022. Horizon Databook has segmented the South Africa bronchodilators market based on beta-adrenergic bronchodilators, anticholinergic bronchodilators, xanthine derivatives covering the revenue growth of each sub-segment from 2018 to 2030.
Reasons to subscribe to South Africa bronchodilators market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of South Africa bronchodilators market databook
-
Our clientele includes a mix of bronchodilators market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the South Africa bronchodilators market, including forecasts for subscribers. This country databook contains high-level insights into South Africa bronchodilators market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
South Africa bronchodilators market report size, by drug class, 2018-2030 (US$M)
South Africa Bronchodilators Market Share, 2022 & 2030 (US$M)
Related industry reports
Related statistics
No records
No related statistics found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
